Joint Formula

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

manganese amino acid chelate, Quantity: 7 mg (Equivalent: manganese, Qty 700 microgram); Curcuma longa, Quantity: 38.46 mg (Equivalent: Curcuma longa, Qty 384.6 mg; Equivalent: curcumin, Qty 25 mg); Zingiber officinale, Quantity: 10 mg (Equivalent: Zingiber officinale, Qty 110 mg); glucosamine sulfate sodium chloride, Quantity: 1.5 g; borax, Quantity: 8.85 mg (Equivalent: boron, Qty 1 mg); bovine sodium chondroitin sulfate, Quantity: 120 mg

Disponible depuis:

Successfield Pty Ltd

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: povidone; maltodextrin; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; croscarmellose sodium; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; macrogol 400; titanium dioxide; Carnauba Wax

Mode d'administration:

Oral

indications thérapeutiques:

Helps maintain/supports healthy joint cartilage growth/development/production ; Helps enhance/promote healthy joint function ; Helps enhance/promote joint health ; Maintain/support joint health ; Maintain/support joint mobility/flexibility ; Helps enhance/improve/promote joint mobility ; Decrease/reduce/relieve mild joint stiffness

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Listed

Date de l'autorisation:

2019-08-26